Clovis Oncology reported $-60289000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agenus AGEN:US $ -50.6M 17M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Astrazeneca AZN:US $ 3709M 624M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Clovis Oncology CLVS:US $ -60.29M 2.06M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Insmed INSM:US $ -94236000 18.78M
Intrexon XON:US $ -19.31M 5.71M
Merk MRK:US $ 6309M 1525M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Veracyte VCYT:US $ -14.46M 3.15M
YTE INCY:US $ 172.84M 1.75M